Tomonobu Mutsumi

Title: Tomonobu Mutsumi: Innovator in Pharmaceutical Crystallization

Introduction

Tomonobu Mutsumi is a notable inventor based in Saitama, Japan. He has made significant contributions to the field of pharmaceutical sciences, particularly in the area of crystallization methods. With a total of 3 patents to his name, Mutsumi's work has implications for drug stability and efficacy.

Latest Patents

Mutsumi's latest patents include innovative methods for obtaining stable crystal forms of pharmaceutical compounds. One of his key inventions is the stable crystal form of tipiracil hydrochloride, which aims to enhance the stability of this important drug. Another notable patent is for the crystal form of 5-chloro-6-(2-iminopyrrolidin-1-yl)methyl-2,4(1H,3H)-pyrimidinedione hydrochloride. This invention exhibits specific powder X-ray diffraction peaks at angles of 11.6°, 17.2°, 17.8°, 23.3°, 27.1°, and 29.3°, which are critical for identifying the crystal structure.

Career Highlights

Mutsumi is currently associated with Taiho Pharmaceutical Company Limited, where he continues to advance his research in pharmaceutical formulations. His work is pivotal in ensuring that medications maintain their effectiveness and safety through improved crystallization techniques.

Collaborations

Mutsumi collaborates with Hideki Kazuno, a fellow researcher, to further explore innovative solutions in the pharmaceutical industry. Their combined expertise enhances the potential for groundbreaking advancements in drug development.

Conclusion

Tomonobu Mutsumi's contributions to pharmaceutical crystallization are noteworthy, as they play a crucial role in the development of stable and effective medications. His innovative patents reflect a commitment to improving drug formulations for better patient outcomes.